News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
586,531 Results
Type
Article (50722)
Company Profile (128)
Press Release (535681)
Section
Business (159566)
Career Advice (2815)
Deals (29935)
Drug Delivery (118)
Drug Development (69632)
Employer Resources (165)
FDA (14977)
Job Trends (13989)
News (283427)
Policy (30705)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (4)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (5)
2024 Biotech Beach Digital (6)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (5)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
Academia (2747)
Academic (2)
Accelerated approval (3)
Adcomms (25)
Allergies (73)
Alliances (41936)
ALS (82)
Alzheimer's disease (1324)
Antibody-drug conjugate (ADC) (102)
Approvals (14946)
Artificial intelligence (216)
Autoimmune disease (13)
Automation (14)
Bankruptcy (295)
Best Places to Work (10729)
BIOSECURE Act (20)
Biosimilars (98)
Biotechnology (85)
Bladder cancer (53)
Brain cancer (26)
Breast cancer (222)
Cancer (1737)
Cardiovascular disease (145)
Career advice (2345)
Career pathing (30)
CAR-T (134)
Cell therapy (363)
Cervical cancer (14)
Clinical research (56266)
Collaboration (646)
Compensation (178)
Complete response letters (24)
COVID-19 (2639)
CRISPR (34)
C-suite (170)
Cystic fibrosis (90)
Data (1607)
Decentralized trials (2)
Denatured (12)
Depression (42)
Diabetes (221)
Diagnostics (6242)
Digital health (18)
Diversity (6)
Diversity, equity & inclusion (41)
Drug discovery (100)
Drug pricing (117)
Drug shortages (30)
Duchenne muscular dystrophy (65)
Earnings (57378)
Editorial (33)
Employer branding (18)
Employer resources (142)
Events (78247)
Executive appointments (543)
FDA (15880)
Featured Employer (30)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (594)
Gene editing (87)
Generative AI (22)
Gene therapy (269)
GLP-1 (713)
Government (4384)
Grass and pollen (4)
Guidances (45)
Healthcare (17076)
Huntington's disease (21)
IgA nephropathy (19)
Immunology and inflammation (95)
Indications (24)
Infectious disease (2763)
Inflammatory bowel disease (115)
Inflation Reduction Act (8)
Influenza (46)
Intellectual property (65)
Interviews (535)
IPO (14120)
IRA (46)
Job creations (3633)
Job search strategy (1976)
Kidney cancer (9)
Labor market (25)
Layoffs (499)
Leadership (17)
Legal (8146)
Liver cancer (61)
Lung cancer (256)
Lymphoma (122)
Machine learning (2)
Management (57)
Manufacturing (255)
MASH (54)
Medical device (11929)
Medtech (11933)
Mergers & acquisitions (16203)
Metabolic disorders (592)
Multiple sclerosis (61)
NASH (20)
Neurodegenerative disease (81)
Neuropsychiatric disorders (28)
Neuroscience (1779)
NextGen: Class of 2025 (6152)
Non-profit (4565)
Northern California (1823)
Now hiring (26)
Obesity (330)
Opinion (249)
Ovarian cancer (58)
Pain (78)
Pancreatic cancer (67)
Parkinson's disease (119)
Partnered (17)
Patents (179)
Patient recruitment (78)
Peanut (43)
People (48195)
Pharmaceutical (33)
Pharmacy benefit managers (20)
Phase I (16891)
Phase II (24624)
Phase III (19590)
Pipeline (802)
Podcasts (69)
Policy (119)
Postmarket research (2227)
Preclinical (6733)
Press Release (69)
Prostate cancer (83)
Psychedelics (37)
Radiopharmaceuticals (209)
Rare diseases (329)
Real estate (5743)
Recruiting (62)
Regulatory (19950)
Reports (37)
Research institute (2503)
Resumes & cover letters (445)
Rett syndrome (2)
RNA editing (1)
RSV (41)
Schizophrenia (67)
Series A (103)
Series B (66)
Service/supplier (9)
Sickle cell disease (47)
Southern California (1531)
Special edition (16)
Sponsored (29)
Startups (3410)
State (2)
Stomach cancer (12)
Supply chain (57)
The Weekly (56)
United States (16440)
Vaccines (649)
Venture capitalists (34)
Webinars (10)
Weight loss (248)
Women's health (30)
Worklife (14)
Date
Today (124)
Last 7 days (658)
Last 30 days (2549)
Last 365 days (30544)
2025 (4977)
2024 (31287)
2023 (35308)
2022 (45806)
2021 (49880)
2020 (48643)
2019 (42991)
2018 (32705)
2017 (29568)
2016 (28542)
2015 (32821)
2014 (25947)
2013 (22861)
2012 (22222)
2011 (22784)
2010 (19995)
Location
Africa (861)
Alabama (43)
Alaska (5)
Arizona (138)
Arkansas (12)
Asia (36016)
Australia (6273)
California (4147)
Canada (1591)
China (376)
Colorado (209)
Connecticut (208)
Delaware (91)
Europe (81175)
Florida (671)
Georgia (155)
Idaho (56)
Illinois (439)
India (18)
Indiana (234)
Iowa (5)
Japan (123)
Kansas (84)
Kentucky (21)
Louisiana (9)
Maine (63)
Maryland (641)
Massachusetts (2892)
Michigan (192)
Minnesota (270)
Mississippi (2)
Missouri (71)
Montana (26)
Nebraska (22)
Nevada (52)
New Hampshire (60)
New Jersey (1319)
New Mexico (26)
New York (1283)
North Carolina (794)
North Dakota (7)
Northern California (1823)
Ohio (171)
Oklahoma (10)
Oregon (29)
Pennsylvania (983)
Puerto Rico (5)
Rhode Island (20)
South America (1227)
South Carolina (13)
South Dakota (1)
Southern California (1531)
Tennessee (70)
Texas (642)
Utah (155)
Virginia (111)
Washington D.C. (52)
Washington State (420)
West Virginia (3)
Wisconsin (34)
586,531 Results for "la jolla institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
La Jolla Institute for Immunology and RevolKa started a Research Collaboration
RevolKa Ltd., a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology agreed to start a research collaboration to create antigens for the next-generation vaccines to deliver innovative solutions to unmet medical need in infectious diseases.
April 18, 2024
·
2 min read
XNK presents at the 8th Innate Killer Summit in La Jolla, San Diego
XNK Therapeutics AB announced its extensive participation at the 8th Annual Innate Killer Summit in La Jolla, San Diego, CA, March 28-30.
March 22, 2023
·
2 min read
Deals
Innoviva to Acquire La Jolla Pharmaceutical Company
Innoviva, Inc. and La Jolla Pharmaceutical Company announced that they have entered into a definitive merger agreement whereby Innoviva will acquire La Jolla.
July 11, 2022
·
10 min read
Press Releases
Agilent Presents Solutions Innovation Research Awards to Institut National de la Recherche Scientifique and University of Southern California Scientists
November 7, 2024
·
4 min read
Deals
Innoviva Completes Acquisition of La Jolla Pharmaceutical
Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”), a diversified holding company with a portfolio of royalties and a growing portfolio of innovative healthcare assets, today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of La Jolla Pharmaceutical Company (Nasdaq: LJPC) (“La Jolla”) at a price of $6.23 per share (the “Offer Price”).
August 22, 2022
·
5 min read
Business
La Jolla Institute for Immunology Acquires the Carterra LSA Platform to Advance State-of-the-Art Immunological and Infectious Disease Research
Carterra, Inc. and La Jolla Institute for Immunology (LJI) announced today that LJI has acquired a Carterra LSA instrument to enhance its antibody screening and characterization work.
August 1, 2022
·
5 min read
Deals
Innoviva Snags Lucrative La Jolla Portfolio in $149M Deal
Innoviva Inc. and La Jolla Pharmaceutical Company announced Monday that they had entered into a $149-million merger agreement.
July 11, 2022
·
3 min read
·
Tristan Manalac
Business
La Jolla Institute renews longtime collaboration with Kyowa Kirin, Inc.
La Jolla Institute for Immunology (LJI) and Kyowa Kirin, Inc. (KKNA), a wholly-owned subsidiary of Kyowa Kirin Co., Ltd (Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical company, today announced the signing of a new collaboration agreement.
January 18, 2022
·
4 min read
Biotech Beach
Equillium Announces Presentation of Data Demonstrating Biological Importance of Multi-Cytokine Inhibitors EQ101 and EQ102 at the La Jolla Immunology Conference
Equillium, Inc. today announced data presented at the annual La Jolla Immunology Conference.
October 26, 2022
·
7 min read
Business
Cumulus Oncology Appoints Catherine Lewis La Torre to its Board of Directors
Cumulus Oncology, Europe’s first oncology-focused biotech company creation factory, announces the appointment of Catherine Lewis La Torre to its Board of Directors.
June 10, 2024
·
3 min read
1 of 58,654
Next
